Preview: Kairos Pharma, Ltd Set To IPO Tomorrow
Preview: Kairos Pharma, Ltd Set To IPO Tomorrow
預覽：凱羅斯醫藥有限公司明天將進行首次公開募股（IPO）
Kairos Pharma, Ltd is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance.Kairo
Kairo
The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on March 11, 2025.
該公司以每股4.00美元的預期價格發行股票，內部鎖定期爲180天，截至2025年3月11日。
See also: Benzinga IPO Calendar
參見：Benzinga IPO日曆
About Kairos Pharma, Ltd
關於Kairos Pharma，Ltd
Kairos Pharma, Ltd is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance.
Kairos Pharma，Ltd是一家臨床階段的生物製藥公司，致力於推動針對癌症患者的治療方案，旨在克服免疫抑制和藥物抗性的關鍵障礙。
See also: Benzinga's Most Shorted Stocks
參見：Benzinga的做空集合股
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動化內容引擎生成並由編輯審查。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。